Skip to Content

OMNICEF 300 mg a (Omnicef 300 mg)

Generic Name: cefdinir

Pill imprint OMNICEF 300 mg a has been identified as Omnicef 300 mg.

Omnicef is used in the treatment of sinusitis; skin or soft tissue infection; skin and structure infection; bronchitis; otitis media (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Omnicef 300 mg is not subject to the Controlled Substances Act.

See also related documents.

Omnicef 300 mg OMNICEF 300 mg a Front
Omnicef 300 mg OMNICEF 300 mg a Back
Omnicef 300 mg OMNICEF 300 mg a
Omnicef 300 mg OMNICEF 300 mg a
Omnicef
Generic Name:
cefdinir
Imprint:
OMNICEF 300 mg
a
Strength:
300 mg
Color:
Purple / Green
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Third generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Abbott Laboratories
National Drug Code (NDC):
00074-3769

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide